07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
08.09.2016
- The state attorney general's office in New York is conducting a probe into whether Mylan Pharmaceuticals unfairly limited competition for its emergency allergy treatment EpiPen...
